Who has invested in 1E Therapeutics?

Marius Nacht are named among the investors backing 1E Therapeutics.

1E Therapeutics Funding: $120M Raised, Seed (2021)

1E Therapeutics funding overview

1E Therapeutics is based in Rehovot, Israel. 1E Therapeutics has raised $120M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Seed announced in December 2021. The round record for 1E Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Marius Nacht.

1E Therapeutics at a glance

Total raised: $120M
Latest round: Seed
Latest round date: December 2021
Headquarters: Rehovot, Israel
Notable investors: Marius Nacht

Frequently asked about 1E Therapeutics funding

How much has 1E Therapeutics raised?: 1E Therapeutics has raised $120M in total disclosed funding across the rounds on record.
Who has invested in 1E Therapeutics?: Marius Nacht are named among the investors backing 1E Therapeutics.
What was the latest 1E Therapeutics funding round?: The most recent disclosed round is a Seed, announced in December 2021.
Where is 1E Therapeutics based?: 1E Therapeutics is based in Rehovot, Israel.
When did 1E Therapeutics last raise?: The last disclosed 1E Therapeutics round closed in December 2021 at Seed.

Every 1E Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Rehovot at a similar stage.

1E Therapeutics Funding: $120M Raised, Seed (2021)

1E Therapeutics funding overview

1E Therapeutics at a glance

Frequently asked about 1E Therapeutics funding

Companies related to 1E Therapeutics (13)

Browse related funding lists (3)